Acrivon Therapeutics (ACRV) IPO deck
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.
![](/content/images/size/w1304/2022/11/Acrivon-01-1.png)
Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.